TAT Technologies director reports RSU holdings
TAT Technologies Ltd director Eitan Oppenhaim reported equity-based holdings in the company.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
TAT Technologies Ltd director Eitan Oppenhaim reported equity-based holdings in the company. The filing shows restricted stock units that can convert into 1,978 ordinary shares, with an exercise price of 0.0000 per share. These RSUs were granted on November 5, 2025 and will fully vest immediately before the first annual shareholder meeting following that grant date, as long as he continues serving as a director through the vesting date. The report also indicates no ordinary shares held directly at this time.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Restricted Stock Units | -- | -- | -- |
| Holding | Ordinary Shares | -- | -- | -- |
Footnotes (2)
- F1. Restricted stock units were granted on November 5, 2025 . 100% of the RSUs shall vest immediately prior to the first annual meeting of the Company's shareholders following the date of grant, subject to the Reporting Person's continued service as a director of the Issuer through such vesting date.
- F2. Each restricted share unit represents the right to receive, upon vesting, one share of the Issuer's ordinary shares
AI-generated analysis. How Rhea-AI works. Not financial advice.